Clinical Trials
Research and Studies Conducted by Lawley Pharmaceuticals
Lawley Pharmaceuticals is continually engaged in the process of developing and testing new treatment options in its selected therapeutic areas of men's and women's health. Specific areas of interest include andrology, gynaecology, urology and endocrinology.
Studies under way which are currently recruiting patients include:
Testosterone Cream Trial
AndroForte® Testosterone Cream is currently being trialled in Adelaide to help men with low levels of testosterone who suffer from symptoms like muscle weakness, lethargy and lack of libido.
Click here to watch the news broadcast about the trial.
The Pharmacokinetics of AndroForte® Compared With AndroGel® (Testogel®) in Androgen Deficient Men
Status: Recruiting January 2011 in Adelaide, South Australia - Principal Investigator: Professor Gary Wittert, Royal Adelaide Hospital.
For more information click here.
Participant Information & Consent Form (237kb).
The Role of Testosterone on Aß Deposition of Alzheimer's disease
Status: Protocols in development. Principal Investigator: Professor Ralph Martins, The McCusker Alzheimer Disease Research Foundation, Inc., Perth, Australia.
For more information please click here.
Completed Clinical Trials
The following clinical trials include:
- Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women.
Wren BG et al. Climacteric 2000 3:155–160.
- Distribution and metabolism of topically applied progesterone in a rat model.
Waddell B and O'Leary PJ. J Ster Biochem & Mol Biol. 80 (2002) 449–455. - Plasma and saliva concentrations of progesterone in pre- and postmenopausal women after topical application of progesterone cream.
O'Leary PJ et al. Presented at the Annual Congress of the Australian Menopause Society held in Perth, Australia in October 1997. - Long-term pharmacokinetics and clinical efficacy of ANDROMEN®FORTE 5% cream for androgen replacement in hypogonadal men.
Handelsman DJ et al. ANZAC Research Institute, Department of Andrology, Concord Hospital, Sydney, 2004. - Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.
Goldstat R et al. Menopause 2003; 10 (5): 390-398. - The pharmacokinetics pilot study of ANDRO-FEME® 1% testosterone cream following two-week, once-daily application in testosterone deficient women.
Eden JA et al. Presented at the 4th Annual Congress of the Australasian Menopause Society held in Adelaide 5-7th November 2000. - A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
El-Hage et al Climacteric 2007; 10: 335–343. - Pharmacokinetics Of Andromen Forte 5% Cream: A Dose Finding Study.
Kelleher S et al. ANZAC Research Institute, Department of Andrology, Concord Hospital, Sydney, 2002.